146 related articles for article (PubMed ID: 12424857)
41. Treatment of locally advanced esophageal cancer with surgery and chemoradiation.
Siersema PD; van Hillegersberg R
Curr Opin Gastroenterol; 2008 Jul; 24(4):535-40. PubMed ID: 18622172
[TBL] [Abstract][Full Text] [Related]
42. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.
Heath EI; Burtness BA; Heitmiller RF; Salem R; Kleinberg L; Knisely JP; Yang SC; Talamini MA; Kaufman HS; Canto MI; Topazian M; Wu TT; Olukayode K; Forastiere AA
J Clin Oncol; 2000 Feb; 18(4):868-76. PubMed ID: 10673530
[TBL] [Abstract][Full Text] [Related]
43. Adjuvant (postoperative) therapy for esophageal cancer.
Ku GY; Ilson DH
Thorac Surg Clin; 2013 Nov; 23(4):525-33. PubMed ID: 24199702
[TBL] [Abstract][Full Text] [Related]
44. Neoadjuvant therapy of esophageal cancer.
Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
[TBL] [Abstract][Full Text] [Related]
45. Preoperative versus postoperative chemoradiotherapy in the trimodality management of esophageal cancer.
Kim C; Monjazeb AM; Suntharalingam M; Giesinger KR; Blackstock AW
Clin Adv Hematol Oncol; 2009 May; 7(5):327-333, 342. PubMed ID: 19521322
[TBL] [Abstract][Full Text] [Related]
46. Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal carcinoma: a phase I report.
Goldberg M; Farma J; Lampert C; Colarusso P; Coia L; Frucht H; Goosenberg E; Beard M; Weiner LM
J Thorac Cardiovasc Surg; 2003 Oct; 126(4):1168-73. PubMed ID: 14566264
[TBL] [Abstract][Full Text] [Related]
47. [Phase III clinical trial for esophageal cancer using radiotherapy].
Ogino T
Gan To Kagaku Ryoho; 1995 Feb; 22(3):341-9. PubMed ID: 7533489
[TBL] [Abstract][Full Text] [Related]
48. [The role of radiotherapy in the management of esophageal cancer].
Serkies K; Badzio A; Jassem J
Pol Merkur Lekarski; 2005 Mar; 18(105):332-5. PubMed ID: 15997646
[TBL] [Abstract][Full Text] [Related]
49. Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base.
Wong AT; Shao M; Rineer J; Osborn V; Schwartz D; Schreiber D
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27860114
[TBL] [Abstract][Full Text] [Related]
50. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990.
Kavanagh B; Anscher M; Leopold K; Deutsch M; Gaydica E; Dodge R; Allen K; Allen D; Staub W; Montana G
Int J Radiat Oncol Biol Phys; 1992; 24(4):633-42. PubMed ID: 1429085
[TBL] [Abstract][Full Text] [Related]
51. Multimodality treatment of esophageal cancer: a review of the current status and future directions.
Ng T; Dipetrillo T; Purviance J; Safran H
Curr Oncol Rep; 2006 May; 8(3):174-82. PubMed ID: 16618381
[TBL] [Abstract][Full Text] [Related]
52. Controversies and Consensus in Preoperative Therapy of Esophageal and Gastroesophageal Junction Cancers.
Ku GY
Surg Oncol Clin N Am; 2017 Apr; 26(2):241-256. PubMed ID: 28279467
[TBL] [Abstract][Full Text] [Related]
53. New developments in the treatment of esophageal cancer.
Ilson DH
Clin Adv Hematol Oncol; 2004 Feb; 2(2):97-104. PubMed ID: 16163169
[TBL] [Abstract][Full Text] [Related]
54. [Neoadjuvant therapy for resectable esophageal cancer].
Hejna M; Raderer M
Z Gastroenterol; 2005 Oct; 43(10):1141-7. PubMed ID: 16220454
[TBL] [Abstract][Full Text] [Related]
55. Outcomes of definitive chemoradiation in patients with esophageal cancer.
Mikhail S; Wei L; Salem ME; Bekaii-Saab T
Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 27868290
[TBL] [Abstract][Full Text] [Related]
56. The current evidence in support of multimodal treatment of locally advanced, potentially resectable esophageal cancer.
Zacherl J
Dig Dis; 2014; 32(1-2):171-5. PubMed ID: 24603404
[TBL] [Abstract][Full Text] [Related]
57. [Radiochemotherapy for esophageal cancer: which nodes should be irradiated?].
Créhange G; Quivrin M; Vulquin N; Serre AA; Maingon P
Cancer Radiother; 2014 Oct; 18(5-6):577-82. PubMed ID: 25201634
[TBL] [Abstract][Full Text] [Related]
58. Combined modality therapy of localized gastric and esophageal cancers.
Das P; Fukami N; Ajani JA
J Natl Compr Canc Netw; 2006 Apr; 4(4):375-82. PubMed ID: 16569390
[TBL] [Abstract][Full Text] [Related]
59. High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.
Lertbutsayanukul C; Tharavej C; Klaikeaw N; Prayongrat A; Lowanitchai C; Sriuranpong V
Thorac Cancer; 2017 May; 8(3):219-228. PubMed ID: 28322515
[TBL] [Abstract][Full Text] [Related]
60. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
Tiesi G; Park W; Gunder M; Rubio G; Berger M; Ardalan B; Livingstone A; Franceschi D
J Surg Res; 2017 Aug; 216():65-72. PubMed ID: 28807215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
